RxDoctor Payments Data

David Mosley, MD

Family Medicine · Camden, ARNPI 1619943271

Payments from drug & device makers

$1,332in general payments, 2019–2025

Across 85 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$323
  • GSK$188
  • Lilly USA, LLC$147
  • Pfizer$139
  • Novo Nordisk$114
  • Exact Sciences$103
  • plus $317 from 9 others

What the payments were for

  • Food & beverage$1,30298%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,332 in reported general payments places this provider in the 60th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$6,305
Medicare patients
90
Services billed
178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide240$256,754
EliquisApixaban239$151,515
Trelegy ElliptaFluticasone/Umeclidin/Vilanter163$105,082
JardianceEmpagliflozin85$65,338
MounjaroTirzepatide45$48,637
XareltoRivaroxaban68$32,999
EntrestoSacubitril/Valsartan30$23,671
SymbicortBudesonide/Formoterol Fumarate82$22,787
JanuviaSitagliptin Phosphate35$21,552
LinzessLinaclotide31$18,297
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog23$14,789
Lantus SolostarInsulin Glargine,hum.Rec.Anlog109$14,295
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen734$13,167
Atorvastatin Calcium1,299$9,806
Breo ElliptaFluticasone/Vilanterol19$9,801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$114$256,754240 claims
PfizerEliquis$139$151,515239 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$188$124,347200 claims
Lilly USA, LLCMounjaro$147$48,63745 claims
AbbVieLinzess, Lumigan$323$24,44543 claims
NovartisEntresto$66$23,67130 claims
MerckJanuvia$52$21,55235 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Camden

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →